SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-22-000090
Filing Date
2022-08-08
Accepted
2022-08-08 16:04:58
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20220630.htm   iXBRL 10-Q 1070473
2 EX-10.1 exhibit101-incyte2ndamend.htm EX-10.1 21468
3 EX-31.1 exhibit31-1q22022.htm EX-31.1 9167
4 EX-31.2 exhibit31-2q22022.htm EX-31.2 9169
5 EX-32.1 exhibit32-1q22022.htm EX-32.1 4097
6 EX-32.2 exhibit32-2q22022.htm EX-32.2 3932
  Complete submission text file 0001125345-22-000090.txt   4887106

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20220630.xsd EX-101.SCH 32160
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20220630_cal.xml EX-101.CAL 40397
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20220630_def.xml EX-101.DEF 182634
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20220630_lab.xml EX-101.LAB 429292
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20220630_pre.xml EX-101.PRE 298789
45 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20220630_htm.xml XML 734370
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 221144289
SIC: 2834 Pharmaceutical Preparations